Page last updated: 2024-09-03

wr 33278 and Neoplasms

wr 33278 has been researched along with Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Capizzi, RL1
Bonner, HS; Glover, DJ; Kligerman, MM; Norfleet, AL; Shaw, LM; Turrisi, AT; Weiler, C1

Reviews

1 review(s) available for wr 33278 and Neoplasms

ArticleYear
The preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies by amifostine.
    Seminars in oncology, 1999, Volume: 26, Issue:2 Suppl 7

    Topics: Amifostine; Animals; Antineoplastic Agents; Cytoprotection; Drug Evaluation, Preclinical; Humans; Mercaptoethylamines; Neoplasms; Neoplasms, Experimental; Prodrugs; Protective Agents; Radiation-Protective Agents; Tumor Cells, Cultured

1999

Other Studies

1 other study(ies) available for wr 33278 and Neoplasms

ArticleYear
Human pharmacokinetics of WR-2721.
    International journal of radiation oncology, biology, physics, 1986, Volume: 12, Issue:8

    Topics: Amifostine; Humans; Kinetics; Mercaptoethylamines; Neoplasms; Organothiophosphorus Compounds; Radiation-Protective Agents; Tissue Distribution

1986